Objective
Progress in the life sciences and related technologies offer great potential for therapeutic benefits to patients in need. However, major adaptations to current paradigms of bringing medicines to patients are required in order to realize that potential and to address important challenges in the healthcare ecosystem.
Against this background, several initiatives are exploring new pathways to market, collectively referred to as Medicines Adaptive Pathways to Patients (MAPPs).
The ADAPT-SMART consortium is aligning a limited number of major stakeholders eager to progress towards MAPPs implementation. It will act as a neutral collaborative platform that will engage industry, SMEs, regulators, Health Technology Assessment bodies (HTAs), payers, governments, clinicians and patients.
The ADAPT-SMART consortium will contribute to align understanding of the impact of MAPPs, to share learnings between all stakeholders, and to allow the field to actively work towards MAPPs implementation.
The impact of the ADAPT-SMART CSA will be a result of the delivery of
• actionable advice/recommendations to IMI on how to best leverage results from past/current projects;
• concrete proposals for future (IMI) projects;
• actionable advice/recommendations and information to other actors in the healthcare environment;
• synthesis of learnings from pilot projects and case studies with relevance to MAPPs;
• communication of CSA outcomes by way of publications and conference presentations.
This CSA will increase the probability of successful implementation of MAPPs and accelerate access to crucial therapies, thus improving the position of both the patients in need of novel treatments and the research-based pharmaceutical industry.
Keywords
Programme(s)
Call for proposal
H2020-JTI-IMI2-2015-04-two-stage-Master
See other projects for this callSub call
H2020-JTI-IMI2-2015-04-two-stage
Funding Scheme
CSA - Coordination and support actionCoordinator
3521 AL Utrecht
Netherlands
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Participants (34)
Participation ended
2300 Kobenhavn
See on map
BRUSSELS Brussels / Bruxelles
See on map
02139 Cambridge
See on map
1083 HS Amsterdam
See on map
OX1 2JD Oxford
See on map
75014 Paris
See on map
M1 4BT Manchester
See on map
93218 Saint Denis La Plaine Cedex
See on map
1112 ZA DIEMEN
See on map
Participation ended
10154 New York
See on map
SL6 4XE Maidenhead
See on map
1831 Diegem
See on map
KT16 0RS Chertsey
See on map
151 85 Sodertaelje
See on map
13353 Berlin
See on map
55218 Ingelheim
See on map
WC1A 1DG LONDON
See on map
91940 Les Ulis
See on map
2340 Beerse
See on map
RG21 4FA Basingstoke
See on map
2500 Valby
See on map
92200 Neuilly Sur Seine
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
64293 Darmstadt
See on map
08889 Whitehouse Station Nj
See on map
4056 Basel
See on map
2880 Bagsvaerd
See on map
CT13 9NJ Sandwich
See on map
4070 Basel
See on map
94250 GENTILLY
See on map
1070 Bruxelles / Brussel
See on map
1050 Bruxelles / Brussel
See on map
00187 Roma
See on map
91190 GIF-SUR-YVETTE
See on map
6300 Zug
See on map